Kronos Bio Inc (KRON)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-07-01 | 2024-06-28 | B Purchase |
PRESIDENT & CEO Executive Director |
204,670
+1.9%
1.25USD 254,957 |
204,670 +1.9% | 1.25 | USD 254,957 | |
| 2024-07-01 | 2024-06-27 | B Purchase |
PRESIDENT & CEO Executive Director |
410,848
+4.0%
1.17USD 478,843 |
410,848 +4.0% | 1.17 | USD 478,843 | |
| 2024-06-12 | 2024-06-12 | B Purchase |
PRESIDENT & CEO Executive Director |
881,913
+13.6%
1.24USD 1,096,041 |
881,913 +13.6% | 1.24 | USD 1,096,041 | |
| 2024-06-12 | 2024-06-11 | B Purchase |
PRESIDENT & CEO Executive Director |
744,308
+12.9%
1.09USD 814,571 |
744,308 +12.9% | 1.09 | USD 814,571 | |
| 2024-06-12 | 2024-06-10 | B Purchase |
PRESIDENT & CEO Executive Director |
1,378,901
+31.6%
0.88USD 1,208,469 |
1,378,901 +31.6% | 0.88 | USD 1,208,469 | |
| 2024-02-23 | 2024-02-21 | S Sale |
SR VP, CLINICAL SCIENCE Officer |
7,368
-3.7%
1.05USD 7,765 |
7,368 -3.7% | 1.05 | USD 7,765 | |
| 2024-02-23 | 2024-02-21 | S Sale |
SR VP, CORP OPERATIONS & LEGAL Officer |
12,105
-5.6%
1.05USD 12,757 |
12,105 -5.6% | 1.05 | USD 12,757 | |
| 2024-02-23 | 2024-02-21 | S Sale |
SR VP, RESEARCH & DEVELOPMENT Officer |
12,036
-4.9%
1.05USD 12,685 |
12,036 -4.9% | 1.05 | USD 12,685 | |
| 2024-01-05 | 2024-01-04 | S Sale |
Chief Scientific Officer Officer |
7,366
-2.7%
1.18USD 8,718 |
7,366 -2.7% | 1.18 | USD 8,718 | |
| 2024-01-05 | 2024-01-04 | S Sale |
Chief Medical Officer & VP Officer |
12,009
-3.7%
1.18USD 14,214 |
12,009 -3.7% | 1.18 | USD 14,214 | |
| 2024-01-05 | 2024-01-04 | S Sale |
COO & General Counsel Officer |
10,676
-1.1%
1.18USD 12,636 |
10,676 -1.1% | 1.18 | USD 12,636 | |
| 2023-12-13 | 2023-12-12 | S Sale |
Chief Scientific Officer Officer |
10,032
-3.6%
1.31USD 13,092 |
10,032 -3.6% | 1.31 | USD 13,092 | |
| 2023-12-13 | 2023-12-12 | S Sale |
Chief Medical Officer & VP Officer |
17,367
-5.0%
1.31USD 22,664 |
17,367 -5.0% | 1.31 | USD 22,664 | |
| 2023-11-17 | 2023-11-17 | B Purchase |
President & CEO Executive Director |
97,935
+4.0%
1.08USD 106,162 |
97,935 +4.0% | 1.08 | USD 106,162 | |
| 2023-11-17 | 2023-11-16 | B Purchase |
President & CEO Executive Director |
262,433
+12.0%
1.00USD 261,514 |
262,433 +12.0% | 1.00 | USD 261,514 | |
| 2023-11-17 | 2023-11-15 | B Purchase |
President & CEO Executive Director |
1,370,688
+169.3%
0.80USD 1,102,718 |
1,370,688 +169.3% | 0.80 | USD 1,102,718 | |
| 2023-07-07 | 2023-07-06 | S Sale |
Chief Scientific Officer Officer |
6,634
-2.3%
1.75USD 11,625 |
6,634 -2.3% | 1.75 | USD 11,625 | |
| 2023-07-07 | 2023-07-06 | S Sale |
Chief Financial Officer Officer |
9,617
-2.7%
1.75USD 16,852 |
9,617 -2.7% | 1.75 | USD 16,852 | |
| 2023-07-07 | 2023-07-06 | S Sale |
Chief Medical Officer & VP Officer |
10,818
-3.0%
1.75USD 18,956 |
10,818 -3.0% | 1.75 | USD 18,956 | |
| 2023-02-24 | 2023-02-24 | S Sale |
Chief Medical Officer & VP Officer |
10,153
-2.8%
1.74USD 17,621 |
10,153 -2.8% | 1.74 | USD 17,621 | |
| 2023-02-24 | 2023-02-24 | S Sale |
Chief Financial Officer Officer |
9,026
-2.5%
1.74USD 15,665 |
9,026 -2.5% | 1.74 | USD 15,665 | |
| 2023-02-24 | 2023-02-24 | S Sale |
Chief Scientific Officer Officer |
6,291
-2.2%
1.74USD 10,918 |
6,291 -2.2% | 1.74 | USD 10,918 | |
| 2022-12-14 | 2022-12-12 | S Sale |
Chief Scientific Officer Officer |
9,138
-5.3%
1.81USD 16,496 |
9,138 -5.3% | 1.81 | USD 16,496 | |
| 2022-12-14 | 2022-12-12 | S Sale |
Chief Medical Officer & VP Officer |
18,657
-7.8%
1.81USD 33,680 |
18,657 -7.8% | 1.81 | USD 33,680 | |
| 2022-05-19 | 2022-05-19 | B Purchase |
President & CEO Executive Director |
300,000
+58.9%
3.78USD 1,134,510 |
300,000 +58.9% | 3.78 | USD 1,134,510 | |
| 2022-05-19 | 2022-05-18 | B Purchase |
President & CEO Executive Director |
206,198
+68.0%
3.72USD 768,046 |
206,198 +68.0% | 3.72 | USD 768,046 | |
| 2022-05-19 | 2022-05-17 | B Purchase |
President & CEO Executive Director |
90,931
+42.8%
3.83USD 348,529 |
90,931 +42.8% | 3.83 | USD 348,529 | |
| 2021-12-15 | 2021-12-13 | S Sale |
Chief Medical Officer & VP Officer |
250
-0.2%
12.82USD 3,206 |
250 -0.2% | 12.82 | USD 3,206 | |
| 2021-12-15 | 2021-12-13 | S Sale |
Chief Medical Officer & VP Officer |
16,152
-12.1%
12.36USD 199,687 |
16,152 -12.1% | 12.36 | USD 199,687 | |
| 2021-12-15 | 2021-12-13 | S Sale |
Chief Scientific Officer Officer |
174
-0.2%
12.82USD 2,231 |
174 -0.2% | 12.82 | USD 2,231 | |
| 2021-12-15 | 2021-12-13 | S Sale |
Chief Scientific Officer Officer |
11,212
-11.6%
12.36USD 138,614 |
11,212 -11.6% | 12.36 | USD 138,614 | |
| 2021-12-08 | 2021-12-06 | B Purchase |
President & CEO Executive Director |
14,356
+7.2%
12.09USD 173,492 |
14,356 +7.2% | 12.09 | USD 173,492 | |
| 2021-12-02 | 2021-12-01 | B Purchase | Non-Executive Director |
1,150
+71.9%
11.57USD 13,306 |
1,150 +71.9% | 11.57 | USD 13,306 | |
| 2021-10-04 | 2021-10-04 | PS Planned sale |
Chief Scientific Officer Officer |
9,189
-8.7%
20.81USD 191,195 |
9,189 -8.7% | 20.81 | USD 191,195 | |
| 2021-08-03 | 2021-08-02 | PS Planned sale |
Chief Scientific Officer Officer |
9,189
-8.7%
20.59USD 189,165 |
9,189 -8.7% | 20.59 | USD 189,165 | |
| 2021-04-20 | 2021-04-20 | PS Planned sale | Non-Executive Director |
19
-0.0%
20.63USD 392 |
19 -0.0% | 20.63 | USD 392 | |
| 2021-04-20 | 2021-04-20 | PS Planned sale | Non-Executive Director |
21,532
-1.6%
20.10USD 432,793 |
21,532 -1.6% | 20.10 | USD 432,793 | |
| 2021-04-20 | 2021-04-19 | PS Planned sale | Non-Executive Director |
4,157
-0.3%
21.38USD 88,877 |
4,157 -0.3% | 21.38 | USD 88,877 | |
| 2021-04-20 | 2021-04-19 | PS Planned sale | Non-Executive Director |
9,847
-0.7%
20.25USD 199,402 |
9,847 -0.7% | 20.25 | USD 199,402 | |
| 2021-04-20 | 2021-04-16 | PS Planned sale | Non-Executive Director |
7,870
-0.6%
21.56USD 169,677 |
7,870 -0.6% | 21.56 | USD 169,677 | |
| 2021-04-20 | 2021-04-16 | PS Planned sale | Non-Executive Director |
25,292
-1.8%
20.84USD 527,085 |
25,292 -1.8% | 20.84 | USD 527,085 | |
| 2021-04-15 | 2021-04-15 | PS Planned sale | Non-Executive Director |
24,818
-1.8%
21.78USD 540,536 |
24,818 -1.8% | 21.78 | USD 540,536 | |
| 2021-04-15 | 2021-04-14 | PS Planned sale | Non-Executive Director |
18,938
-1.3%
23.10USD 437,468 |
18,938 -1.3% | 23.10 | USD 437,468 | |
| 2021-04-15 | 2021-04-14 | PS Planned sale | Non-Executive Director |
13,698
-1.0%
22.38USD 306,561 |
13,698 -1.0% | 22.38 | USD 306,561 | |
| 2021-04-15 | 2021-04-13 | PS Planned sale | Non-Executive Director |
1,285
-0.1%
25.18USD 32,356 |
1,285 -0.1% | 25.18 | USD 32,356 | |
| 2021-04-15 | 2021-04-13 | PS Planned sale | Non-Executive Director |
5,738
-0.4%
24.40USD 140,007 |
5,738 -0.4% | 24.40 | USD 140,007 | |
| 2021-04-15 | 2021-04-13 | PS Planned sale | Non-Executive Director |
9,997
-0.7%
23.35USD 233,430 |
9,997 -0.7% | 23.35 | USD 233,430 | |
| 2020-10-16 | 2020-10-14 | B Purchase | Non-Executive Director |
75,800
+4.0%
19.00USD 1,440,200 |
75,800 +4.0% | 19.00 | USD 1,440,200 | |
| 2020-10-16 | 2020-10-14 | B Purchase | Non-Executive Director Large shareholder |
450,000
+13.4%
19.00USD 8,550,000 |
450,000 +13.4% | 19.00 | USD 8,550,000 | |
| 2020-10-16 | 2020-10-14 | B Purchase |
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust Large shareholder |
95,500
+2.2%
19.00USD 1,814,500 |
95,500 +2.2% | 19.00 | USD 1,814,500 | |
| 2020-10-16 | 2020-10-14 | B Purchase | Large shareholder |
450,000
+13.4%
19.00USD 8,550,000 |
450,000 +13.4% | 19.00 | USD 8,550,000 | |
| 2020-10-16 | 2020-10-14 | B Purchase |
President & CEO Executive Director |
95,500
+2.2%
19.00USD 1,814,500 |
95,500 +2.2% | 19.00 | USD 1,814,500 | |
| 2020-10-16 | 2020-10-14 | B Purchase |
Chief Financial Officer Officer |
5,250
+16.4%
19.00USD 99,750 |
5,250 +16.4% | 19.00 | USD 99,750 | |
| 2020-10-16 | 2020-10-14 | B Purchase |
Chief Scientific Officer Officer |
5,250
+inf%
19.00USD 99,750 |
5,250 +inf% | 19.00 | USD 99,750 | |
| 2020-10-16 | 2020-10-14 | B Purchase |
COO & General Counsel Officer |
5,250
+0.9%
19.00USD 99,750 |
5,250 +0.9% | 19.00 | USD 99,750 | |
| 2020-10-16 | 2020-10-14 | B Purchase | Non-Executive Director |
2,630
+inf%
19.00USD 49,970 |
2,630 +inf% | 19.00 | USD 49,970 |